AAREYDRUGS NSE filing

Book Closure for 35th Annual General Meeting

The RealCase readLow impact Neutral

Why it matters

Book closure for AGM is a routine event and has a low impact on the company's value.

The market read

The announcement is about the book closure for the Annual General Meeting, which is a routine corporate event.

* Register of Members and Share Transfer books will be closed from 23 September 2025 to 29 September 2025 for the 35th Annual General Meeting.

Filing to action

What to do with a filing like this

Aarey Drugs & Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Aarey Drugs & Pharmaceuticals Limited. Read the original for the full detail.

View original filing